Evaxion Biotech AS (EVAX)
0.919
+0.03
(+3.25%)
USD |
NASDAQ |
Dec 20, 16:00
0.9018
-0.02
(-1.87%)
After-Hours: 20:00
Evaxion Biotech Enterprise Value: 0.8149M for Dec. 20, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Novo Nordisk AS | 374.83B |
| Ascendis Pharma AS | 8.324B |
| DBV Technologies SA | 19.71M |
| Adaptimmune Therapeutics PLC | 18.53M |
| Akari Therapeutics PLC | 22.77M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.935M |
| Revenue (Quarterly) | 3.017M |
| Total Expenses (Quarterly) | 4.748M |
| EPS Diluted (Quarterly) | -0.40 |
| Profit Margin (Quarterly) | -64.14% |
| Earnings Yield | -304.7% |
| Normalized Earnings Yield | -271.37 |